Background:
Tic disorders (TDs) are a group of neurodevelopmental disorders in children, while pharmacotherapy is often associated with various side effects and has limited clinical effects for some patients, thus significantly affecting patients’ quality of life. Studies have found acupuncture shows certain advantages in the treatment of TDs. However, there is no high level of evidence evaluating the effectiveness and safety of acupuncture for children with TDs.
Methods:
Each data of acupuncture for treating TDs will be searched. We will search for related English and Chinese databases. The time is limited from inception until November 2020. The primary outcome is the reduction rate (amount) of tic severity using related scales or methods, and the secondary outcomes include recurrence rate and adverse events. The risk of bias will be assessed, and the RevMan5.3 and Stata14.0 will be performed for meta-analysis. Finally, we will assess the level of the resulting evidence.
Results:
The results of the study will synthesize the current evidence and be published in peer-reviewed journals.
Conclusions:
This research aims to provide convincing evidence of the effectiveness and safety of acupuncture for treating TDs in children.
INPLASY registration number:
INPLASY2020110050.
Review question / Objective: Types of participants£ŗAll infant patients diagnosed with enteritis (aged 5 and under , with no lower age limit) will be included in the study. We will follow the Medicine clinical practice guidelines of acute infectious diarrhea from 2018 Children"AEs Hospital of Zhejiang University School or Diagnosis and Guidelines for clinical Practice of Acute infectious diarrhoeal diseases in INPLASY 1
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.